Combining aromatase inhibitors (AIs) and growth hormone (GH) was shown to increase the height potential in pubertal boys with idiopathic short stature (ISS) when compared to treating ISS with either drug separately, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Nelly Mauras, MD, of Nemours Children’s...
International survey finds many wait years for diagnosis of common reproductive, metabolic health problem A large international survey of women with a common condition called polycystic ovary syndrome (PCOS), which is characterized by reproductive and metabolic problems, found nearly two in three were dissatisfied with the length of time they waited and the number of...
Most women have never heard of genitourinary syndrome of menopause. But given its prevalence and progressive nature, many physicians are working to increase attention and treatment. Some 50% of postmenopausal women will experience the symptoms of genitourinary syndrome of menopause (GSM) at some point, but few women receive treatment — even though safe and effective...
Doses can be tailored to compensate for individual risk factors, protect bone health Individualized supplement doses help protect pregnant women from vitamin D deficiency, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. The research found vitamin D supplements are less effective at raising vitamin D levels in pregnant...
Researchers call for further study to reduce risk of depression, side effects Men can take birth control shots to prevent pregnancy in their female partners, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Researchers are still working to perfect the combination of hormonal contraceptives to reduce the risk...
Women who experience premature or early-onset menopause may be at a greater risk of coronary hear disease, cardiovascular disease (CVD) mortality, and all-cause mortality, according to a study recently published in JAMA Cardiology. Researchers led by Taulant Muka, MD, PhD, of Erasmus University Medical Center, Rotterdam, the Netherlands, and noted that as many as 10% of...
Hypoestrogenic women who perceive a high number of nighttime hot flashes and experience/have sleep disruption are more vulnerable to menopause-associated depressive symptoms, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Hadine Joffe, MD, MSc, of Brigham and Women’s Hospital and Dana Farber Cancer Institute at Harvard Medical...
The Endocrine Society on Thursday will host a Twitter chat focused on polycystic ovary syndrome (PCOS) to coincide with women’s health month, moderated by Society member Genevieve S. Neal-Perry, MD, PhD, who directs the University of Washington Medicine’s Reproductive Endocrinology and Infertility Center. Nearly 10 percent of women have PCOS, and it is one of the...
Most women have never heard of genitourinary syndrome of menopause. But given its prevalence and progressive nature, many physicians are working to increase attention and treatment. Some 50% of postmenopausal women will experience the symptoms of genitourinary syndrome of menopause (GSM) at some point, but few women receive treatment — even though safe and effective...
